AR110357A1 - Proceso para preparar inhibidores de btk - Google Patents
Proceso para preparar inhibidores de btkInfo
- Publication number
- AR110357A1 AR110357A1 ARP170103487A ARP170103487A AR110357A1 AR 110357 A1 AR110357 A1 AR 110357A1 AR P170103487 A ARP170103487 A AR P170103487A AR P170103487 A ARP170103487 A AR P170103487A AR 110357 A1 AR110357 A1 AR 110357A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- reaction mixture
- reaction
- forming
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
- B01J31/2414—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicación 1: Un método para preparar compuesto de fórmula [1], sus estereoisómeros, sus isómeros geométricos, sus tautómeros y sus sales, el método comprende: (i) (1) formar una primera mezcla de reacción que comprende compuesto de fórmula [2], compuesto de fórmula [3], un catalizador de paladio, un sistema disolvente que comprende agua y una base, en donde la relación de volumen de solvente a peso de compuesto de fórmula [2] en la mezcla de reacción es menos de 20:1 litros por kg, la proporción de equivalentes de compuesto de fórmula [3] a compuesto de fórmula [2] es más de 1:1, y la proporción de equivalentes del catalizador de paladio a compuesto de fórmula [2] es de aproximadamente 0,005:1 a aproximadamente 0,05:1, (2) hacer reaccionar la primera mezcla de reacción para formar una primera mezcla de productos de reacción que comprende compuesto de fórmula [4] de acuerdo con el esquema [i], y (3) aislar compuesto de fórmula [4] de la primera mezcla de productos de reacción; y (ii) (1) formar una segunda mezcla de reacción que comprende compuesto de fórmula [4], un agente reductor, una base y un solvente, (2) hacer reaccionar la segunda mezcla de reacción para reducir el resto aldehído del compuesto de fórmula [4] y formar una segunda mezcla de productos de reacción que comprende compuesto de fórmula [1], y (3) aislar compuesto de fórmula [1] de la segunda mezcla de productos de reacción, en donde el rendimiento de compuesto de fórmula [4] se basa por lo menos 50% en compuesto de fórmula [2] y el rendimiento de compuesto de fórmula [1] se basa por lo menos 50% en compuesto de fórmula [4]. Reivindicación 50: Un método para preparar compuesto de fórmula [1], sus estereoisómeros, sus isómeros geométricos, sus tautómeros y sus sales, el método comprende: (i) (1) formar una primera mezcla de reacción que comprende compuesto de fórmula [2], un agente reductor, una base y un solvente, para reducir el resto aldehído de compuesto de fórmula [2] para formar compuesto de fórmula [5], y (2) aislar compuesto de fórmula [5] de la primera mezcla de productos, (ii) (1) formar una segunda mezcla de reacción que comprende compuesto de fórmula [5], compuesto de fórmula [6], un catalizador de paladio, un sistema disolvente que comprende agua, y una base, para formar compuesto de fórmula [1], y (2) aislar compuesto de fórmula [1] de la segunda mezcla de productos, de acuerdo con el esquema [ii].
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434569P | 2016-12-15 | 2016-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR110357A1 true AR110357A1 (es) | 2019-03-20 |
Family
ID=61007648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170103487A AR110357A1 (es) | 2016-12-15 | 2017-12-13 | Proceso para preparar inhibidores de btk |
| ARP220101839A AR126445A2 (es) | 2016-12-15 | 2022-07-13 | Metodo para preparar inhibidores de btk |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220101839A AR126445A2 (es) | 2016-12-15 | 2022-07-13 | Metodo para preparar inhibidores de btk |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10385058B2 (es) |
| EP (3) | EP3825317A3 (es) |
| JP (2) | JP6800334B2 (es) |
| KR (2) | KR102257159B1 (es) |
| CN (2) | CN111333656B (es) |
| AR (2) | AR110357A1 (es) |
| AU (4) | AU2017376580B2 (es) |
| CA (2) | CA3104116A1 (es) |
| ES (1) | ES2894262T3 (es) |
| HR (1) | HRP20211553T1 (es) |
| IL (2) | IL284690B (es) |
| MX (2) | MX386843B (es) |
| PL (1) | PL3555099T3 (es) |
| SG (2) | SG10202009148XA (es) |
| SI (1) | SI3555099T1 (es) |
| TW (3) | TWI766176B (es) |
| WO (1) | WO2018109050A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3825317A3 (en) | 2016-12-15 | 2021-07-28 | F. Hoffmann-La Roche AG | Process for preparing btk inhibitors |
| US11100492B2 (en) | 2018-02-19 | 2021-08-24 | Peter Garrett | General purpose re-loadable card aggregation implementation |
| US20210221792A1 (en) * | 2020-01-16 | 2021-07-22 | Hanmi Pharm Co., Ltd. | Convergent synthesis of poziotinib derivative |
| CN119925375A (zh) | 2020-02-20 | 2025-05-06 | 和记黄埔医药（上海）有限公司 | 杂芳基杂环化合物及其用途 |
| US20230348471A1 (en) * | 2020-06-18 | 2023-11-02 | Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | Bruton's tyrosine kinase inhibitor and preparation method therefor |
| CA3195525A1 (en) | 2020-09-21 | 2022-03-24 | Hutchison Medipharma Limited | Heteroaryl heterocyclic compounds and uses thereof |
| WO2022206924A1 (zh) * | 2021-04-02 | 2022-10-06 | 南京明德新药研发有限公司 | 含氮三并环双功能化合物及其制备方法和应用 |
| EP4334311B1 (en) | 2021-05-05 | 2024-12-25 | F. Hoffmann-La Roche AG | Process for preparing btk inhibitors |
| CN113603685A (zh) * | 2021-07-23 | 2021-11-05 | 都创(上海)医药开发有限公司 | Fenebrutinib化合物的晶型及其制备方法和用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3431541A1 (de) * | 1984-08-28 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung |
| US7432375B2 (en) * | 2003-03-06 | 2008-10-07 | Eisai R & D Management Co., Ltd. | JNK inhibitors |
| AU2006229995A1 (en) * | 2005-03-25 | 2006-10-05 | Glaxo Group Limited | Process for preparing pyrido(2,3-d)pyrimidin-7-one and 3,4-dihydropyrimido(4,5-d)pyrimidin-2(1H)-one derivatives |
| US8440830B2 (en) | 2007-09-19 | 2013-05-14 | 4Sc Ag | Tetrahydro-fused pyridines as histone deacetylase inhibitors |
| JP5469604B2 (ja) * | 2007-09-19 | 2014-04-16 | ４エスツェー アクチェンゲゼルシャフト | 新規テトラヒドロ融合ピリジン |
| CN101781312B (zh) * | 2009-12-30 | 2012-09-26 | 中国科学院广州生物医药与健康研究院 | 一种吲哚衍生物的合成方法 |
| ES2573716T3 (es) * | 2010-05-07 | 2016-06-09 | Gilead Connecticut, Inc. | Compuestos de piridona y aza-piridona y métodos de utilización |
| JP5976828B2 (ja) * | 2011-11-03 | 2016-08-24 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Ｂｔｋ活性阻害剤としてのアルキル化ピペラジン化合物 |
| UA111756C2 (uk) | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
| US9076830B2 (en) * | 2011-11-03 | 2015-07-07 | Applied Materials, Inc. | Robot systems and apparatus adapted to transport dual substrates in electronic device manufacturing with wrist drive motors mounted to upper arm |
| US8722676B2 (en) * | 2011-11-03 | 2014-05-13 | Genentech, Inc. | Bicyclic piperazine compounds |
| US8703953B2 (en) * | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
| TW201427970A (zh) * | 2012-10-12 | 2014-07-16 | Univ Health Network | 激酶抑制劑及使用其治療癌症的方法 |
| US9670162B2 (en) * | 2013-03-14 | 2017-06-06 | The Board Of Trustees Of The Leland Stanford Junio | Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof |
| TWI513371B (zh) * | 2013-07-08 | 2015-12-11 | Lextar Electronics Corp | 整合無線暨有線的照明控制系統 |
| RU2646758C2 (ru) * | 2013-12-05 | 2018-03-07 | Ф. Хоффманн-Ля Рош Аг | Гетероарил пиридоны и азапиридоны с электрофильной функциональностью |
| TWI659019B (zh) * | 2014-02-28 | 2019-05-11 | 日商帝人製藥股份有限公司 | 吡唑醯胺衍生物 |
| DE102015206627A1 (de) | 2014-07-09 | 2016-01-28 | Siemens Aktiengesellschaft | Selbstsichernder Umrichter |
| JP6507234B2 (ja) * | 2014-10-02 | 2019-04-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ブルトンチロシンキナーゼ（ｂｔｋ）によって介入される障害の処置における使用のためのピラゾールカルボキサミド化合物 |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| PT3233103T (pt) | 2014-12-18 | 2021-01-18 | Principia Biopharma Inc | Tratamento de pênfigo |
| CA2984586C (en) * | 2015-04-29 | 2021-02-16 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor |
| ES2913494T3 (es) * | 2016-02-29 | 2022-06-02 | Hoffmann La Roche | Composiciones de forma farmacéutica que comprenden un inhibidor de tirosina cinasa de Bruton |
| EP3825317A3 (en) * | 2016-12-15 | 2021-07-28 | F. Hoffmann-La Roche AG | Process for preparing btk inhibitors |
-
2017
- 2017-12-13 EP EP20189072.0A patent/EP3825317A3/en active Pending
- 2017-12-13 ES ES17832491T patent/ES2894262T3/es active Active
- 2017-12-13 EP EP25170183.5A patent/EP4574828A3/en active Pending
- 2017-12-13 WO PCT/EP2017/082723 patent/WO2018109050A1/en not_active Ceased
- 2017-12-13 CN CN202010294389.0A patent/CN111333656B/zh active Active
- 2017-12-13 CA CA3104116A patent/CA3104116A1/en active Pending
- 2017-12-13 AR ARP170103487A patent/AR110357A1/es active IP Right Grant
- 2017-12-13 SG SG10202009148XA patent/SG10202009148XA/en unknown
- 2017-12-13 EP EP17832491.9A patent/EP3555099B1/en active Active
- 2017-12-13 TW TW108126347A patent/TWI766176B/zh active
- 2017-12-13 MX MX2020012097A patent/MX386843B/es unknown
- 2017-12-13 SG SG10201913918UA patent/SG10201913918UA/en unknown
- 2017-12-13 KR KR1020197016973A patent/KR102257159B1/ko active Active
- 2017-12-13 AU AU2017376580A patent/AU2017376580B2/en active Active
- 2017-12-13 KR KR1020207037471A patent/KR102375771B1/ko active Active
- 2017-12-13 HR HRP20211553TT patent/HRP20211553T1/hr unknown
- 2017-12-13 SI SI201730936T patent/SI3555099T1/sl unknown
- 2017-12-13 JP JP2019528485A patent/JP6800334B2/ja active Active
- 2017-12-13 PL PL17832491T patent/PL3555099T3/pl unknown
- 2017-12-13 TW TW106143737A patent/TWI673271B/zh active
- 2017-12-13 CA CA3039090A patent/CA3039090C/en active Active
- 2017-12-13 IL IL284690A patent/IL284690B/en unknown
- 2017-12-13 CN CN201780076739.2A patent/CN110446710B/zh active Active
- 2017-12-13 TW TW108126350A patent/TW201940489A/zh unknown
- 2017-12-13 MX MX2019005527A patent/MX379000B/es unknown
- 2017-12-14 US US15/841,828 patent/US10385058B2/en active Active
-
2019
- 2019-02-26 IL IL265067A patent/IL265067B/en unknown
- 2019-07-02 US US16/460,889 patent/US10882864B2/en active Active
-
2020
- 2020-02-21 AU AU2020201261A patent/AU2020201261B2/en active Active
- 2020-02-21 AU AU2020201260A patent/AU2020201260B2/en active Active
- 2020-11-23 US US17/102,086 patent/US11661424B2/en active Active
- 2020-11-24 JP JP2020194373A patent/JP7153705B2/ja active Active
-
2021
- 2021-02-18 AU AU2021201052A patent/AU2021201052A1/en not_active Abandoned
-
2022
- 2022-07-13 AR ARP220101839A patent/AR126445A2/es unknown
-
2023
- 2023-04-12 US US18/299,622 patent/US20230250103A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR110357A1 (es) | Proceso para preparar inhibidores de btk | |
| Anxionnat et al. | FeCl3-catalyzed Ritter reaction. Synthesis of amides | |
| AR114631A1 (es) | Métodos e intermedios para preparar compuestos de piridina | |
| PE20211237A1 (es) | Preparacion de nicotina racemica mediante reaccion de etil nicotinato con n-vinilpirrolidona en presencia de una base de alcoholato y etapas de proceso posteriores | |
| AR120456A1 (es) | Síntesis mejorada del compuesto inhibidor de g12c de kras | |
| PE20100487A1 (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable | |
| AR077526A1 (es) | Metodo para la sintesis de (1s,2r)- milnacipran | |
| MX2017009161A (es) | Procedimiento continuo para prepara etilenglicol a partir de una fuente de carbohidratos. | |
| ES2567081T3 (es) | Producción continua de sales cuaternarias | |
| Teplov et al. | Synthesis of new compounds combining adamantanamine and monoterpene fragments and their antiviral activity against influenza virus A (H1N1) pdm09 | |
| AR107494A1 (es) | Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y azd9291 anilina o una sal de la misma | |
| AR088296A1 (es) | Citramida de rasagilina, proceso de preparación y composicion farmaceutica | |
| AR095365A1 (es) | Procedimiento para preparar compuestos benzoxazepina | |
| MX385690B (es) | Método novedoso para producir 4,5-dihidroisoxazol 5,5-disustituido. | |
| CL2022000904A1 (es) | Proceso para la preparación de compuestos representados por las fórmulas iv, vii y ia; y un polimorfo del compuesto de fórmula ia (div. sol. 202001814). | |
| MX355215B (es) | Sintesis de derivados de metanuro de 7-acetileno quinona y su aplicacion como retardantes de polimerizacion vinilica. | |
| Schmid et al. | Selective NaOH-catalysed hydration of aromatic nitriles to amides | |
| AR084864A1 (es) | Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso | |
| AR116423A1 (es) | Un proceso de fabricación de compuestos heterocíclicos de 2-nitroimino | |
| MX2017001459A (es) | Sintesis de fosforamidatos. | |
| MX381350B (es) | Proceso para la preparacion de 1,4-bis (etoximetil) ciclohexano. | |
| AR120485A1 (es) | Un proceso de flujo continuo para la síntesis del ácido hidroxámico | |
| MX2019000138A (es) | Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble. | |
| FR3064006B1 (fr) | Procede de fabrication de l'acide-2-hydroxy-4-methylthio-butyrique | |
| ES181424A1 (es) | UN PROCEDIMIENTO PARA LA SiNTESIS DE ÉTERES DE VITAMINA A |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |